Shares of Chinese payment firms surged following news of yuan being accepted for tolls in the Strait of Hormuz. This signals China's efforts to internationalize the yuan and potentially attract more global investments amid ongoing conflicts in Iran.
1 min read3 Apr 2026AVIC Chengdu shares have declined 12% so far in March. The company manufactures fighter jets like the J-16. Additionally, China Aerospace Times Electronics, a manufacturer of aerospace electronics and unmanned system equipment, has lost 13% during this period.
2 min read19 Mar 2026China's equity markets will shut for the Lunar New Year from February 16 to 23, 2026, affecting trading across Asia. US markets will also be closed on February 16 for Presidents' Day, leading to reduced global liquidity and trading activity.
2 min read16 Feb 2026Among the top-performing Chinese mining companies of this year are: Hunan Silver Co, Zijin Mining Group Co, Jiangxi Copper Co, Shandong Gold Mining and CMOC Group.
2 min read29 Dec 2025Regulators over the summer reopened a pathway for unprofitable startups in strategic industries to go public.
2 min read12 Dec 2025Moore Threads, a Beijing-based GPU manufacturer, made a strong market today, with shares debuting 468% to 650 yuan. The IPO raised 8 billion yuan, signaling investor confidence in China's tech policies despite U.S. sanctions. The company aims for significant revenue growth and profitability by 2027.
2 min read5 Dec 2025Years of heavy investing by Baidu, Alibaba and Tencent in artificial intelligence and advanced chips are bearing fruit.
3 min read17 Sep 2025Avic Chengdu share price has dropped 24% amid a stable selloff, despite China's military display. The stock's inability to hold above 100 yuan points to ongoing weakness, with analysts predicting further declines towards the 70 zone unless buyers return.
2 min read9 Sep 2025On Monday, Avic Chengdu Aircraft share price touched an intraday high to 108.22 yuan. The fighter jet stock opened at 102.20 yuan on September 1, as compared to previous close of 101.95 yuan.
2 min read1 Sep 2025Jiangsu Hengrui Pharmaceuticals' shares surged 10% to a 4-year high after licensing HRS-9821 and 11 programs to GlaxoSmithKline. GSK will pay $500 million upfront, with potential milestones reaching $12 billion, focusing on COPD treatments and collaboration on further development.
2 min read28 Jul 2025Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.